Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-029337

Director sold 1,666 shares at an average $62.15 ($103,538)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-28 Sale : show line 1 in the form −381 $60.71 $23,129 137,040 D
2021-04-28 Sale : show line 2 in the form −597 $62.05 $37,042 136,443 D
2021-04-28 Sale : show line 3 in the form −688 $63.03 $43,367 135,755 D
Open-market sales · 1,666 sh · avg $62.15 · $103,538
Loading xslF345X03/doc4.xml…